
KPC Pharmaceuticals, Inc.
SSE:600422.SS
15.47 (CNY) • At close June 6, 2025
Overzicht | Financiële gegevens
Bedrijfsnaam | KPC Pharmaceuticals, Inc. |
Symbool | 600422.SS |
Munteenheid | CNY |
Prijs | 15.47 |
Beurswaarde | 11,710,418,720 |
Dividendpercentage | 0.69% |
52-weken bereik | 11.92 - 21.44 |
Industrie | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Xianggang Zhong |
Website | https://www.kpc.com.cn |
An error occurred while fetching data.
Over KPC Pharmaceuticals, Inc.
KPC Pharmaceuticals, Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemether, panax notoginseng, and gastrodine series drugs, as well as Chinese medicines and ethnic drugs under the Luotai, Tianxuanqing, Artemedine,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CNY)
Cijfers zijn in miljoenen (CNY)